WayPoint Biomedical Holdings, Inc.
OTC: WYPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Industrials
- Industry
- Specialty Business Services
- CEO
- John Richer
- Employees
- 1
- Headquarters
- Las Vegas, United States
- IPO year
- 2015
- Market cap
- $43.2K
- Website
- https://www.wyperion.com
Loading WYPH…
Loading profile data…Frequently asked questions about WYPH
What does WayPoint Biomedical Holdings, Inc. (WYPH) do?
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine,...
Where does WYPH trade?
WayPoint Biomedical Holdings, Inc. (WYPH) trades on the Other OTC.
What sector is WYPH in?
WayPoint Biomedical Holdings, Inc. (WYPH) operates in the Industrials sector, specifically in the Specialty Business Services industry.
Who is the CEO of WayPoint Biomedical Holdings, Inc.?
John Richer is the chief executive officer of WayPoint Biomedical Holdings, Inc. (WYPH).
Where is WayPoint Biomedical Holdings, Inc. headquartered?
WayPoint Biomedical Holdings, Inc. is headquartered in United States.
Does WYPH pay a dividend?
WayPoint Biomedical Holdings, Inc. (WYPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WYPH go public?
WayPoint Biomedical Holdings, Inc. (WYPH) completed its initial public offering in 2015.